SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
HOOKIPA Pharma Inc. (HOOK) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+167.9%).
- 分析师共识目标价 $3.00 (+167.9% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 54/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — HOOK
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.32
EV/EBITDA0.0
每股数据
EPS (TTM)$-3.47
每股账面价值$0.00
每股营收$3.50
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$3.00 (+167.9%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2017 |
$-139.54 |
$0.00 |
$-12.72M |
- |
| 2018 |
$-177.57 |
$7.63M |
$-16.24M |
-212.8% |
| 2019 |
$-24.10 |
$11.94M |
$-43.04M |
-360.4% |
| 2020 |
$-16.93 |
$19.58M |
$-44.08M |
-225.1% |
| 2021 |
$-23.04 |
$18.45M |
$-75.67M |
-410.2% |
| 2022 |
$-9.91 |
$14.25M |
$-64.92M |
-455.6% |
| 2023 |
$-8.63 |
$20.13M |
$-81.58M |
-405.3% |
| 2024 |
$-3.47 |
$43.95M |
$-43.5M |
-99% |
